We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of the century. Several significant recent developments suggest that this revolutionary new technology is about to start realising its potential, which could clearly be significant for investors and constituents of our high-performing Mega Trends portfolio which rose 76% in 2020. Find out more in our update here.
CRISPR/Cas9enables the editing of DNA; that’s all. It means we can edit the fundamental building blocks of nature that make us who we are. It also has the potential to wipe out certain diseases, radically improve crop yields, but a certain Vladimir Vladimirovich Putin once argued that genetic engineering “may be more terrifying than a nuclear bomb.”
Search for AIM companies qualifying for relief from Inheritance Tax!
Use our unique screening tool to identify Inheritance Tax planning AIM companies
This search will take you to the separate AIMsearch web site which requires a different user name and password to this Investor's Champion site.
Investor’s Champion, making your money go further.
ABOUT INVESTORS CHAMPION
Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.
Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at Fourth & Fifth Floor, 14-15 Lower Grosvenor Place, London, England, SW1W 0EX.